Goda resultat för Novavax covid-vaccin i fas 3-studie

Novavax vaccin mot covid-19 uppvisade en effekt på över 90 procent mot covid-19 och skyddade helt mot måttlig till svår sjukdom, enligt studieresultat som föret...

Trio goes in for high tech medicines

The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.

Infidelity produces faster sperms

Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.

Asarina drar igång klinisk Tourette-studie

Bioteknikbolaget Asarina Pharma har inlett en fas IIa-studie med läkemedelskandidaten Sepranolon vid Tourettes syndrom.

"Precisionsmedicin är på agendan hos varenda bioteknikföretag"

Flera utmaningar kvarstår för att skräddarsydd immunterapi ska nå fram.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Sales Representative, Applied Biosystems

Hälften av dödsfallen i covid-19 har skett på vårdboenden

Av alla dödsfall som det nya coronaviruset skördat i Europa har omkring hälften drabbat personer som bott på vårdboenden. Detta enligt en ny rapport som The Gur...

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

Viktig forskarvän fyller 150 år

Denna banbrytande idé kan i år stoltsera med hela 150 år på nacken. Det är nämligen så länge sedan Dmitrij Mendelejev presenterade sin första version av periodiska systemet.

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...

Biotage is regrouping

The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.

Cancer cells cheat suicide call

Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of...

Årets opinionsartiklar

Missa inte de opinionsartiklar som har blivit mest lästa i Life Science Sweden.

Bio engineering breakthrough in Denmark

Brand new research makes BioGasol's cellulosic ethanol process even more competitive.

Hon ska leda EIT Health Scandinavia

Annika Szabo Portela har utsetts till vd för EIT Health Scandinavia. Hon har sedan december arbetat som operativ interim vd, men anställs nu permanent.

Pfizer drar tillbaka artiklar

Utredning visar att sex artiklar om onkologi från läkemedelsjätten Pfizer innehåller förfalskade data. En av personerna bakom forskningen har lämnat bolaget.

Discovery of new role for leukemia gene

Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell d...

Age essential when testing drugs

Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Lytix calls in cash

Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.

Olink expanderar i USA

Nyligen gjorde Uppsalabolaget Olink en lyckad börsnotering på New York-börsen. Nu planerar företaget att utöka personalstyrkan både i Sverige och i USA.